Literature DB >> 16405965

Raf-1 kinase associates with Hepatitis C virus NS5A and regulates viral replication.

T Bürckstümmer1, M Kriegs, J Lupberger, E K Pauli, S Schmittel, E Hildt.   

Abstract

Hepatitis C virus (HCV) is a positive-strand RNA virus that frequently causes persistent infection associated with severe liver disease. HCV nonstructural protein 5A (NS5A) is essential for viral replication. Here, the kinase Raf-1 was identified as a novel cellular binding partner of NS5A, binding to the C-terminal domain of NS5A. Raf-1 colocalizes with NS5A in the HCV replication complex. The interaction of NS5A with Raf-1 results in increased Raf-1 phosphorylation at serine 338. Integrity of Raf-1 is crucial for HCV replication: inhibition of Raf-1 by the small-molecule inhibitor BAY43-9006 or downregulation of Raf-1 by siRNA attenuates viral replication.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16405965     DOI: 10.1016/j.febslet.2005.12.071

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  27 in total

1.  Subviral Hepatitis B Virus Filaments, like Infectious Viral Particles, Are Released via Multivesicular Bodies.

Authors:  Bingfu Jiang; Kiyoshi Himmelsbach; Huimei Ren; Klaus Boller; Eberhard Hildt
Journal:  J Virol       Date:  2015-12-30       Impact factor: 5.103

Review 2.  New and experimental therapies for HCV.

Authors:  Arema A Pereira; Ira M Jacobson
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-07       Impact factor: 46.802

Review 3.  Hepatocellular carcinoma and liver transplantation: clinical perspective on molecular targeted strategies.

Authors:  Yasunobu Matsuda; Takafumi Ichida; Manabu Fukumoto
Journal:  Med Mol Morphol       Date:  2011-09-16       Impact factor: 2.309

4.  Expanding the proteome of an RNA virus by phosphorylation of an intrinsically disordered viral protein.

Authors:  Daniel G Cordek; Tayler J Croom-Perez; Jungwook Hwang; Michele R S Hargittai; Chennareddy V Subba-Reddy; Qingxia Han; Maria Fernanda Lodeiro; Gang Ning; Thomas S McCrory; Jamie J Arnold; Hasan Koc; Brett D Lindenbach; Scott A Showalter; Craig E Cameron
Journal:  J Biol Chem       Date:  2014-07-16       Impact factor: 5.157

5.  The Intracellular Cholesterol Transport Inhibitor U18666A Inhibits the Exosome-Dependent Release of Mature Hepatitis C Virus.

Authors:  Fabian Elgner; Huimei Ren; Regina Medvedev; Daniela Ploen; Kiyoshi Himmelsbach; Klaus Boller; Eberhard Hildt
Journal:  J Virol       Date:  2016-11-28       Impact factor: 5.103

6.  Hepatitis B virus inhibits insulin receptor signaling and impairs liver regeneration via intracellular retention of the insulin receptor.

Authors:  Sebastian Robert Barthel; Regina Medvedev; Thekla Heinrich; Sarah Manon Büchner; Nadja Kettern; Eberhard Hildt
Journal:  Cell Mol Life Sci       Date:  2016-05-07       Impact factor: 9.261

7.  Hepatitis C virus impairs the induction of cytoprotective Nrf2 target genes by delocalization of small Maf proteins.

Authors:  Monica Carvajal-Yepes; Kiyoshi Himmelsbach; Stephanie Schaedler; Daniela Ploen; Janis Krause; Leopold Ludwig; Thomas Weiss; Karin Klingel; Eberhard Hildt
Journal:  J Biol Chem       Date:  2011-01-07       Impact factor: 5.157

8.  The anti-viral effect of sorafenib in hepatitis C-related hepatocellular carcinoma.

Authors:  R Cabrera; A R Limaye; P Horne; R Mills; C Soldevila-Pico; V Clark; G Morelli; R Firpi; D R Nelson
Journal:  Aliment Pharmacol Ther       Date:  2012-10-24       Impact factor: 8.171

9.  TARGETING THE NS5A PROTEIN OF HCV: AN EMERGING OPTION.

Authors:  D G Cordek; J T Bechtel; A T Maynard; W M Kazmierski; C E Cameron
Journal:  Drugs Future       Date:  2011-09       Impact factor: 0.148

10.  The Autophagosomal SNARE Protein Syntaxin 17 Is an Essential Factor for the Hepatitis C Virus Life Cycle.

Authors:  Huimei Ren; Fabian Elgner; Bingfu Jiang; Kiyoshi Himmelsbach; Regina Medvedev; Daniela Ploen; Eberhard Hildt
Journal:  J Virol       Date:  2016-06-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.